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Abstract 
Multiple sclerosis (MS) is a common neurological disease, estimated to affect 100,000 
people in the UK. Bowel symptoms are reported to be common in MS, with constipation 
affecting 29-43% and faecal incontinence affecting just over 50%. Both have an impact on 
quality of life. Very little is known about how people with MS manage their bowels and the 
effectiveness of different interventions. We conducted a 2-part survey of people with MS and 
bowel problems. MS Society members were invited to participate in an online survey: 155 
replied. 47 people additionally filled in a more detailed postal questionnaire. In this self-
selected sample, 34% spend more than 30 minutes a day managing their bowel. Managing 
bowel function was rated as having an impact equal to mobility difficulties on quality of life. 
Respondents used a wide range of strategies to manage their bowel but few were rated as 
very helpful. There is a need for high quality research on all aspects of managing bowel 
dysfunction in MS in order to improve patients’ quality of life. 
Keywords: Multiple sclerosis, Bowel function, Constipation, Faecal incontinence, Quality of 
life 
 
Multiple sclerosis (MS) is a common neurological disease, estimated to affect 100000 people 
in the UK (MS Society, 2009). It is characterized by focal demyelination and plaque 
formation in the central nervous system. The effects of MS are very variable, depending on 
the individual’s pattern of demyelination. Onset is most usually in the third or fourth decade 
of life, but first symptoms can occur at any age in adulthood. Early symptoms can be mild, 
intermittent and ambiguous, and there may be considerable delay between the onset of 
symptoms and a definitive diagnosis. Several patterns may be distinguished, the three main 
types being: 
• Relapsing-remitting  
• Primary progressive  
• Secondary progressive.  
 
Bowel symptoms are reported to be common in MS, with constipation affecting 29-43% and 
faecal incontinence affecting just over 50% (Hinds et al, 1990; Hennessey et al, 1999). 
Upper gut symptoms such as difficulty swallowing are also widespread (Hinds and Wald, 
1989). Constipation is reported to pre-date diagnosis in many cases, and may be an early 
non-specific symptom of the disease (Hinds et al, 1990).  
Occasionally, severe constipation is the first presenting symptom of MS (Lawthom et al, 
2003). There is a considerable overlap between constipation and faecal incontinence 
(Coggrave et al, 2003; Nordenbo, 1996), with more than 40% of people with MS reporting 
one or both, even among those with mild disability (Eidelman and Wald 1990; Chia et al, 
1995; Bakke et al, 1996).  
Bowel problems have been found to be associated with more severe disability, disease 
progression, and depression, but not necessarily with gender (Bakke et al, 1996). The bowel 
problems associated with specific sub-types of MS have not been identified. Bowel 
dysfunction was reported long ago as the third most significant factor limiting the ability of 
people with MS to work (Bauer et al, 1965), but no more recent work on the impact of bowel 
function, or coping methods could be found. 
People with MS have been found to have 2-3 times as many admissions to hospital as the 
non-neurological population for impaction, megacolon, constipation and volvulus, according 
a survey of 4 million USA hospital admissions (Sonnenberg et al, 1994). Despite this high 
prevalence, there has been little attention on bowel dysfunction.  
One review found that of 18000 publications on MS in the medical literature over 30 years, 
only 30 focused on bowel problems (Wiesel et al, 2001), mostly focusing on prevalence and 
defining physiological mechanisms. Practical coping measures for bowel dysfunction has 
received little attention in people with MS, with a complete absence of intervention studies 
(Wiesel et al, 2001; Coggrave et al, 2006). Indeed a Cochrane review of neurological bowel 
management found only 12 randomized controlled trials of management across all 
neurological conditions.  
It is not known if the burden of bowel dysfunction could be improved by targeted 
interventions, although one small case study has suggested that some problems are 
reversible (Wiesel et al, 2000). 
The survey 
The present survey was triggered by a Multiple Sclerosis (MS) Society member’s letter about 
constipation which was printed in the society’s newsletter MS Matters. This letter generated 
one of the largest postbags ever received by the MS Society (over 100 letters or emails, 
according to D. Reeves, MS Society). Many people wrote at length about the bowel 
problems that they experience. This survey aimed to explore the issue in more detail in order 
to describe the impact bowel dysfunction has on the lives of people with MS, and to identify 
interventions that MS Society members find helpful that may warrant further investigation. 
Methods  
All the letters and emails (with personal identification removed) that were received in 
response to the letter were read, and a simple thematic analysis was used to identify 
recurring themes. These were used to formulate questions for the survey.  
The questionnaires were then examined by staff of the MS Society, and by people with MS, 
to ensure that relevant information had been included, and to check the clarity of the 
questions. Amendments were made to the questions in light of this feedback. 
We conducted a two-stage survey: an initial brief online survey (compiled using Survey 
Monkey®), and a more comprehensive questionnaire for people who were willing to give 
further details. The latter could be printed off from a computer and completed by hand to be 
returned by post.  
An invitation to participate in the survey appeared in the MS Society newsletter MS Matters, 
with details of how to access it online. It was specifically aimed at people with MS. The 
survey was posted on the MS Society website for a period three months following the 
circulation of the newsletter. Respondents were invited to contact the researchers if they had 
any queries regarding completion of the questionnaires or the study. 
Consent was taken as implied by the choice to participate in the survey. No personal 
identification of respondents was requested. Ethical approval for this study was granted by 
Harrow Ethics Research Committee. 
Respondents 
One hundred and fifty five people with MS completed the online survey and 47people 
returned the second print-off questionnaire. There were missing responses to some 
questions.  
Results from the online survey 
Respondents were predominantly female (77%), with a median age of 50 years (range 19-
73). They reported all types of MS and a range of mobility (see Table 1). More than two-
thirds did not feel that their bowel function was affected by a relapse in their MS. 
More than 60% reported constipation and 30% faecal incontinence, with nearly 20% 
experiencing both (Table 2). Other bowel problems were described in free text. The most 
common was urgency of defecation (8 people), which was often reported to alternate with 
constipation. Four respondents reported other bowel conditions: Crohn’s disease (2) and 
irritable bowel syndrome (2).  
Respondents used the free text section to discuss these symptoms in more depth:  
‘Difficulty in emptying bowel, the message from the brain not connecting with the 
sphincter muscles.’ 
‘I often find I can’t go to the toilet even though I feel I need to go, and if I leave it too 
long I will have an urgency problem.’ 
‘Mainly constipation but when I then need to empty my bowel, urgency sometimes 
leads to ‘accidents’.’ 
Laxatives were the most commonly used and the most helpful bowel management method 
for constipation. However, respondents used a range of methods to treat constipation, as 
well as standard methods listed in Table 3 
Respondents discussed how certain positions while sitting on the toilet assisted defecation:  
‘Lean forward on loo then sit upright while pushing, may have to repeat several 
times.’ 
‘When seated on the loo, bending as far forward as possible with head down 
sometimes helps.’ 
They also reported that development of a regular bowel habit is important. Diet and exercise 
was found to be helpful, particularly high fibre diet consisting of fruit, vegetables and bran 
products.  
Three respondents found linseed seeds very helpful, and two respondents found yogurt 
based products helped to maintain a regular bowel habit. It was apparent that respondents 
experimented with different methods in order to manage their symptoms.  
Management methods for faecal incontinence included the use of particular foods or diet, 
which was reported as the most helpful strategy (Table 4). 
Eight respondents reported the need to wear pads especially when leaving home and five 
respondents reported that they always ensure a toilet is within close proximity: 
‘Make sure near toilet and don’t go out too often.’ 
Some respondents reported that they would not leave home until after defaecation occurred 
which meant that they may remain at home all day: 
‘Try to go to the toilet early in the day so that I can go out and be fairly safe that I 
won’t have any disasters. I do not stray far from a toilet, so although I love the 
country I rarely go there to walk as I used to.’ 
It appears from the free text comments that faecal incontinence appeared to have a much 
more profound effect on quality of life than symptoms of constipation. 
Respondents were asked about the effect of their bowel symptoms on their everyday life (0= 
not at all – 10 = a great deal). Figure 1 shows the results. The median response was 6, with 
the full range of responses used. 
Results from posted questionnaire 
Forty seven respondents also printed a PDF of a more detailed questionnaire, which was 
completed by hand and returned by post.  
The age range of the respondents was 28 to 76 years old with the average (mean) age 
being 58 years. Again the respondents were predominantly female (93.6%). Obstetric injury 
due to forceps delivery can cause faecal incontinence so we were keen to elicit if the female 
respondents had children which may have contributed to development of bowel symptoms. 
74% of women had at least one child and 40% of the women had experienced a forceps or 
ventouse–assisted delivery.  
The start of MS symptoms ranged from 2 years to 48 years with the mean being 20 years. 
23.4% of respondents stated that bowel symptoms were the first symptoms of MS and 
70.2% stated that bowel problems were linked to relapses in their condition which is a 
complete contrast to the result reported in the online survey: 
‘Has been worsening with the progression of MS over time’ 
‘Never had bowel problems before MS’ 
‘Bowel incontinence with relapse in 2006’ 
Apart from one, all respondents reported problems with their bladder function. Some had 
multiple bladder problems (Table 5). 
All forty seven respondents reported taking at least one medication (range 1-13, median 3). 
Forty five listed medications, including anti-depressants, diazepam, analgesia, proton pump 
inhibitors, and medications for symptoms of bladder and bowel dysfunction.  
Respondents were asked about their usual bowel pattern and when their bowel function is 
‘at its worst’. Many (44.8%) reported that usually they opened their bowels every other day 
and only 4.2% reported opening their bowel several times a day. However, when their bowel 
function was ‘at its worst’ the majority of respondents (31.9%) reported opening their bowels 
several times a day.  
Respondents were asked about faecal incontinence (FI): 38.3% reported FI ‘most of the 
time’ (1 or more episodes a week but not daily). An additional 31.9% reported one or more 
episodes of FI during the past four weeks, making a total of 70.2% of respondents with FI at 
least monthly.  
Interestingly, most respondents did not experience difficulty opening their bowels (44.7%), 
not needing to strain to assist defecation. However, 42.6% reported difficulty in completely 
evacuating their bowels ‘some of the time’ (1 or more episodes during the past four weeks) 
and 23.4% reported this occurring ‘most of the time’ (1 or more episodes a week but not 
daily). 
Respondents were asked what methods/strategies they used to manage their symptoms of 
incontinence. Fourteen respondents either avoided high fibre or ate high fibre foods which 
they found moderately helpful. Twelve respondents used medication which included beta 
blockers, bowel irrigation, laxatives and anti-diarrhoeal agents. 
Only three respondents reported using complementary therapy (acupuncture, colonic 
irrigation and reflexology). Pilates was recorded as ‘other treatments for faecal incontinence’. 
In respect of constipation, 31 respondents took laxatives, 18 used suppositories and eight 
respondents used enemas with mixed results. Eighteen respondents used digital stimulation 
to initiate defecation and 16 respondents manually evacuated their bowel. Twenty three 
patients used abdominal massage. Six patients used reflexology and one of these also used 
homeopathy and aromatherapy. Other treatments for constipation included high fibre diets, 
dried and fresh fruit and linseed oil and exercise. Bowel treatment methods which were 
unsuccessful for some respondents were listed as helpful for other respondents such as 
linseed oil, Fybogel and suppositories. 
Thirteen people needed someone to help them with their bowel management. Family 
member/partner was the main person who helped (7respondents). Other people reported 
district nurse (2), paid carer (1) and someone else (2). The two respondents who indicated 
this category did not state the role of this person. 
Respondents reported that they spent a variable amount of time daily on bowel management 
(Table 6). Three reported spending 2 hours on their bowel management daily. As 
demonstrated by Table 7, this had a significant impact on their lifestyle. 
Respondents were asked to rate their current bowel function where 0 = terrible, worst 
possible, to 10 = perfect. The median response was 4 (Figure 2). They were also asked to 
rate, overall, how much bowel function interferes with everyday life, where 0 = not at all and 
10 = a great deal (Figure 3). The median response was six. 
Respondents were then asked to compare bowel function and management of their bowel 
with other symptoms that people with MS experience (See Table 8). The question sought to 
elicit if bowel symptoms detrimentally affected quality of life more than other symptoms 
commonly experienced with MS. Each symptom was scored between 1 -10 where 1 = least 
effect and 10 = worst effect. 
Further Information 
At the end of the questionnaire, respondents were provided with a free text section to record 
further information about their bowel function. Twenty three respondents provided 
information regarding: 
Constipation 
‘Constipation is the hardest aspect of MS. Have to get up at 6.30am to make my 
bowels work’ 
‘Constipation due to neuro-muscular problem’ 
Faecal incontinence  
‘Bowel problems are immense - little to no control, problem with mobility when 
needing to rush. Urinary problems totally controlled by ISC + Sheath + Bag. If only 
there were something similar for bowel problems’ 
‘One of the worst aspects is not knowing when I need to empty my bowels. Try to 
empty every time I go to the toilet just in case. Sometimes get leakage’ 
Both faecal incontinence and constipation: 
‘Have to wait between 7 & 10 days between movements. Get cramps 24 hours 
before emptying bowels which give sense of urgency, have learnt when the cramps 
get to a certain intensity that it is time to go to the toilet. Straining only causes 
haemorrhoids and leakage. Fibre makes it worse’ 
One person stated:  
‘This is the worst problem with MS’. 
Discussion 
This was a purposive sample of people self-identifying as having a problem with their bowel 
function. We recognize a possible bias in the sample, as only MS Society members with 
computer access were able to participate (who may or may not be representative of the 
entire MS population). Those who responded are more likely to experience significant bowel 
dysfunction than those who do not experience the problem.  
However, it is apparent that among the range of symptoms experienced by people with MS, 
both questionnaires demonstrated that bowel dysfunction and bowel management had the 
greatest negative impact on their quality of life. This was reflected in both their responses to 
questions and qualitative feedback they provided.  
Medication was found to be the most helpful intervention for managing faecal incontinence 
and constipation, and people were prescribed a range of medication for both bladder and 
bowel dysfunction. However, people with MS experience a range of different physical and 
psychological symptoms, and pharmacological interventions for these symptoms can impact 
on each other, causing further difficulties (Bywater and While, 2006; Crayton and Rossman, 
2006). Some respondents highlighted the need for a bowel assessment - Nortvedt et al 
(2007) stated that symptoms such as bladder, bowel and sexual dysfunction should be 
discussed at the early states of the disease. Their study discovered that although only a few 
people have these symptoms as presenting features of MS, people 2–5 years post MS 
diagnosis reported significant difficulties. Also it appears if people with MS receive higher 
levels of social support at an earlier stage of their MS they will report significantly better 
quality of life (McCabe et al, 2009). Social support does not only relate to friends and family 
but also support from health and social care professionals. 
Many people with MS were spending a lot of time (one third more than 30 minutes per day) 
on bowel function. This has been found in other neurological conditions such as spinal cord 
injury (Coggrave et al, 2008), where psychological status has been found to be inversely 
related to length of time spent on bowel management (the longer the time spent on bowel 
management the worse the individuals psychological status) (Glickman and Kamm, 1996). It 
was evident that people with MS would try a range of interventions to improve their 
symptoms, although most reported only limited effectiveness from most interventions used. 
We did not gather information on previously tried interventions, which had subsequently 
been abandoned.  
Conclusion 
This survey has found that some people with MS experience bowel dysfunction that 
significantly impacts their life. People use a range of interventions to help manage these 
symptoms, with varying degrees of success. There is a need for further development and 
evaluation of bowel interventions to establish effective bowel management strategies.  
Generally, people experiencing bowel symptoms feel stigmatized and are reluctant to inform 
health professionals. If the nurse introduces the topic it can provide an opportunity for the 
person to express their concerns and ask further questions. It was evident that many of the 
respondents of this survey would have welcomed this discussion. Nurses need to be aware 
that discussion and assessment of bowel function is imperative for people with MS. 
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Table 1. Respondents to the internet survey 
 
 Number Percentage 
Type of MS   
Relapsing/remitting 56 36.1 
Secondary  progressive 47 30.3 
Primary progressive 26 16.8 
Don’t know 26 16.8 
Mobility   
Completely  unaided 48 31 
With a stick 50 32.2 
With a frame 12 7.7 
Need  to use a wheelchair    43 27.8 
No answer  given 2 1.3 
Bowel problems linked to relapses in MS   
Yes 42 27.1 
No 109 70.3 
No answer  given 4 2.6 
 
 
Table 2. Types of bowel  problems 
Bowel problem Number Percentage 
None 1 0.6 
Constipation  or difficulty emptying the bowel 66 42.6 
Faecal incontinence 20 12.9 
Both constipation and faecal incontinence 29 18.7 
Other bowel  problem   27 17.4 
No answer  given 12 7.7 
 
Table 3. Bowel management  methods for constipation/evacuation difficulties 
Bowel 
management method 
Number of 
Respondents 
Not at all 
helpful  
Slightly 
helpful 
Moderately 
helpful 
Very 
helpful 
Laxatives 84  12 22 29 21 
Suppositories 38 8 8 9 13 
Enemas 19 7 2 2 8 
Abdominal  massage 42 9 19 7 7 
Complementary therapy 15 5 3 2 5 
Digital stimulation 38 5 8 16 9 
Manual evacuation 30 3 8 9 10 
 
Table 4. Bowel management  methods for faecal  incontinence 
 
Bowel 
management method 
Number of 
Respondents 
Not at all 
helpful  
Slightly 
helpful 
Moderately 
helpful 
Very 
helpful 
Particular foods/diet 44 8 12 15 12 
Medication 59 10 6 7 9 
Complementary therapy 71 10 0 1 1 
 
Table 5. Types of bladder conditions 
Bladder problems (multiple boxes could be 
ticked) 
Number of respondents Percentage 
Stress urinary incontinence 14 29.8 
Urgency 33 70.2 
Urge urinary incontinence 29 61.7 
Bed wetting 5 10.6 
Difficulty emptying the bladder 17 36.2 
Need  to use an intermittent catheter 11 23.4 
Need  to use an indwelling  catheter 7 14.9 
Need  to wear a pad for bladder  leakage 19 40.4 
Need  to use a collection appliance  for bladder  
leakage 
3 6.4 
 
Table 6. Time spent  on bowel  management  daily 
Duration Number of respondents Percentage 
Up to 5 minutes 7 14.9 
5 - 15 minutes 13 27.6 
16 - 30 minutes 11 23.4 
31 - 60 minutes 7 14.9 
More than 1 hour    7 14.9 
No response 2 4.3 
 
Table 7. Bowel management  and lifestyle 
 
Effect on lifestyle No response Not at all (%) A little (%) A lot (%) 
I fit my life around  my bowel  
management 
4 4 (8.5) 17 (36.2) 22 (46.8) 
Bowel management stops me 
working outside  my home 
8 22 (46.8) 10 (21.3) 7 (14.9) 
Managing  my bowels  
interfereswith personal  
relationships 
6 20 (42.5) 14 (29.8) 7 (14.9) 
Bowel management stops  
me staying away from home 
5 16 (34) 17 (36.2) 9 (19.1) 
My bowel  management is a 
problem  to me 
2 0 17 (36.2) 28 (59.6) 
Bowel management 
interferes with my social life 
3 13 (27.6) 22 (46.8) 9 (19.1) 
 
Table 8. Impact of MS symptoms  on quality of life 
MS symptoms 1 2 3 4 5 6 7 8 9 10 N/A No 
response 
Median 
response 
Managing  my 
bladder 
4 2 1 3 7 6 3 5 2 7 4 3 6 
Changes  in my 
sexual function 
6 4 3 1 4 2 1 1 2 5 16 2 5 
Changes  to 
my memory 
10 4 3 4 5 2 2 3 1 0 10 3 4 
Changes  to 
m y  v i s i o n  
9 1 4 2 5 3 0 3 1 2 15 3 3 
Dif ficulty with 
mobility 
2 3 1 2 8 4 2 6 7 5 3 3 7 
Taking care of 
my skin 
12 3 2 3 2 1 1 1 0 1 18 3 2 
Managing  my 
bowel 
1 2 1 3 4 4 7 7 5 7 3 3 7 
Living with 
chronic pain 
9 4 4 0 3 3 2 2 3 5 14 3 3 
Living with 
spasticity 
6 4 4 3 3 3 2 7 2 1 9 3 5 
 
Figure 1. Reported  effect of bowel problems on everyday life 
 
Figure 2. Rating of current bowel function 
  
Figure 3. Impact of bowel function on lifestyle 
 
